Anthos Therapeutics announced the publication of positive results from its AZALEA-TIMI 71 study in the •New England Journal of...

Tiziana Life SciencesLife Sciences has discovered new immune biomarkers in patients with non-active secondary progressive multiple sclerosis (na-SPMS) treated...

Cullgen Inc., a clinical-stage biopharmaceutical company, has initiated human trials for CG001419, a potential first-in-class, oral, pan-TRK protein degrader...

Lisata Therapeutics announced preliminary data from Cohort A of its Phase 2 ASCEND trial evaluating certepetide, combined with standard...

Helius Medical Technologies announced positive results from their PoNSTEP study, demonstrating the long-term benefits of PoNS Therapy for gait...

Coherus BioSciences announced final data from its Phase 2 trial of casdozokitug (casdozo), an IL-27-targeting antibody, combined with atezolizumab...

In this interview, we engage with David Craig from Sarcomatrix Therapeutics to discuss the development of S-969, a novel...

In this interview, we speak with Peter Weinstein, co-founder of Emervax. The discussion delves into Emervax’s innovative circular RNA...

Allurion Technologies received a patent for its enhanced, next-generation gastric balloon technology, specifically for its improved valve system. This...

Kiromic BioPharma announced positive efficacy results from its Deltacel-01 Phase 1 clinical trial of Deltacel™, an allogeneic, off-the-shelf Gamma...